AprilBio Co., Ltd. develops long-acting biobetters and antibody biologics. Its pipeline includes antibody drugs, bispecific antibodies, long-acting antibody and protein drugs, and ADC-based antibodies. These products target rare diseases, cancer, male infertility, and autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.